Effect of anti-inflammatory drugs on overall risk of common cancer: Case-control study in general practice research database

British Medical Journal

Volumn 320, Issue 7250, 2000, Pages 1642-1646

  Langman, M J S ^a   Cheng, K K ^a   Gilman, E A ^a   Lancashire, R J ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER DIAGNOSIS; CANCER PREVENTION; CANCER RISK; CASE CONTROL STUDY; COLON CANCER; CONTROLLED STUDY; DATA BASE; ESOPHAGUS CANCER; FEMALE; GENERAL PRACTICE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM CANCER; STOMACH CANCER; UNITED KINGDOM;

EID: 0034679222     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.320.7250.1642     Document Type: Article

References (24)

1. 1 Giovannucci E, Rimm EG, Stampfer MJ, Colditz GA, Ascherio A, Willett WC. Aspirin use and the risk of colorectal cancer and adenoma in male health professionals. Ann Intern Med 1994;121:241-6.
2. 2 Thum MJ, Namboodiri MM, Calle EE, Flanders DW, Heath CW Jr. Aspirin use and risk of fatal cancer. Cancer Res 1993;53:1322-7.
3. 3 Kkan R, Knispel HH, Meier T. Acetylsalicylic acid inhibition of N-butyl 1-hydroxybutyl nitrosamine-induced bladder carcinogenesis in rats. J Cancer Res Clin Oncol 1993;119:482-5.
4. 1 Robertson FM, Parnett ML, Joarder FS, Ross M, Abou-Issa HM, Alshafie G, et al. Ibuprofen-induced inhibition of cyclo-oxygenase gene expression and regression of rat mammary carcinomas. Cancer Letters 1998;112:165-75.
5. 5 Reddy BS, Rao CV, Rivenson A, Kelloff G. Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F341 rats. Carcinogenesis 1993;14:1193-7.
6. 6 Van Staa T, Abenheim L. The quality of information on a UK database of primary care records: a study of hospitalisation due to hypoglycaemia and other conditions. Pharmacoepidermiol Drug Safety 1994;3:15-21.
7. 7 Giovannucci E, Egan KM, Hunter DJ. Stampfer MJ, Colditz GA, Willett WC, et al. Aspirin and the risk of colorectal cancer in women. New Engl J Med 1995;333:609-14.
8. 8 Paganini-Hill A, Hsu G, Ross RK, Henderson BE. Aspirin use and incidence of large bowel cancer in a California retirement community. J Natl Cancer Inst 1991;83:1182-3.
9. 9 Schreinermachers DM, Everson RB. Aspirin use and lung, colon and breast cancer incidence in a prospective study. Epidemiology 1994;5: 138-46.
10. 10 Gridley G, McLaughlin JK, Ekbom A, Klareskog L, Adami HO, Hacker DG, et al. Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 1993:85:307-1.
11. 11 Isomaki HA, Hakulinen T, Joutsenlahti U, Excess risk of lymphomas, leukaemia and myeloma in patients with rheumatoid arthritis. J Chron Dis 1978;31:691-6.
12. 12 Funkhouser GM, Sharp GB. Aspirin and the reduced risk of esophageal carcinoma. Cancer 1995;76:116-9.
13. 13 Farrow DC, Vaughan TL, Hansten PD, Stanford JL, Risch HA, Gammon MD, et al. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev 1998;7:97-102.
14. 14 Egan KM, Stampfer MJ, Giovannucci E, Rosner BA, Colditz GA. Prospective study of regular aspirin use and the risk of breast cancer. J Natl Cancer Inst 1996;88:988-93.
15. 15 Paganini-Hill A, Chao A, Ross RK, Henderson BE. Aspirin use and chronic disease: a cohort study of the elderly. BMJ 1989;299: 1247-50.
16. 16 Harris RE, Namboodiri KK, Farrar WD. Non-steroidal anti-inflammatory drugs and breast cancer Epidemiology 1996;7:203-5.
17. 17 Friedman GD, Ury HK. Screening for possible drug carcinogenicity: second report of findings. J Natl Cancer Inst 1983;71:1165-75.
18. 18 Norrish AE, Jackson RT, McRae CU. Non-steroidal anti-inflammatory drugs and prostate cancer progression. Int J Cancer 1998;77:511-5.
19. 19 Langman MJS, Weil J, Wainwright P, Lawson DH, Rawlins MD, Logan RFA, et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994;343:1075-8.
20. 20 Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Upregulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994;107:1183-8.
21. 21 Gustafson-Svard C, Lilja I, Hallbrook O, Sjodahl R. Cyclooxygenase-1 and cyclooxygenase-2 gene expression in human colorectal adenocarcinomas and in azoxymethane-induced colonic tumours in rats. Gutt 1996;38:79-88.
22. 22 Hwang D, Scollard D, Byrne J, Levene E. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst 1998;90:455-60.
23. 23 Wilson KT, Fu S, Ramanujam KS, Meltzer SJ. Increased expression of inducible nitric oxide synthase and cyclo oxygenase-2 in Barrett's oesophagus and associated adenocarcinomas. Cancer Res 1998;58: 2929-34.
24. 24 Ristamaki A, Honkanen N, Jankala H, Sipponen P, Hankonen M. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 1997;57:1276-80.